|
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'26 | $4.02 | - | - |
| Q4'25 | $4.23 | $4.67 | +10.5% |
| Q4'24 | $3.12 | $3.68 | +18.1% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'26 | $697M | - | - |
| Q4'25 | $691M | $708M | +2.5% |
| Q4'24 | - | $537M | - |
Market Data
MEDP is currently trading at $419.94, giving MEDP a market cap of 12.15B and a P/E ratio of 26.9. Today's range spans $416.97–$442.41, with shares opening at $421.44 and moving up $0.00 (0.0%) from the prior close. DailyIQ's technical score sits at 32/100 (SELL) with a news sentiment reading of 56/100.
Over the past year MEDP has traded between $250.05 and $628.92 - the current price is +67.9% off the 52-week low and -33.2% from the high.
MEDP (MEDP) is a large-cap in Healthcare with 12.15B in market cap, and the current technical read is bearish. Score: 32/100 (SELL). Sentiment: neutral at 56/100. Price: $419.94 (in the middle of its 52-week range). The current P/E ratio stands at 26.9. The 52-week range of $250.05–$628.92 provides the structural context, and the current SELL designation suggests that prior support levels are more important to watch than usual.
When a large-cap Healthcare name with 12.15B in capitalization prints a SELL signal (32/100) alongside neutral news sentiment (56/100), the risk isn't just price depreciation — it's the loss of institutional sponsorship that makes recovery harder. At $419.94 (in the middle of its 52-week range in the $250.05–$628.92 range), the structural support levels are where that sponsorship question gets answered.
Most recent articles, ranked by recency (click to expand).
Sentiment gathered from recent headlines